SLC22A2/OCT2 Antibody (640438) [DyLight 594]
Novus Biologicals, part of Bio-Techne | Catalog # FAB6547M
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunohistochemistry
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Monoclonal Mouse IgG2A Clone # 640438
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
NS0 mouse myeloma cell line transfected with human SLC-22A2
Accession # O15244
Accession # O15244
Specificity
Detects human SLC22A2 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for SLC22A2/OCT2 Antibody (640438) [DyLight 594]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: SLC22A2/OCT2
Long Name
Organic Cation Transporter 2
Alternate Names
OCT2
Gene Symbol
SLC22A2
Additional SLC22A2/OCT2 Products
Product Documents for SLC22A2/OCT2 Antibody (640438) [DyLight 594]
Product Specific Notices for SLC22A2/OCT2 Antibody (640438) [DyLight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...